# Gary Fegel

> Gary Fegel is a seed investor at GMF Capital backing Bitcoin and Security. See 3 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: Angel Investor
- Fund: [GMF Capital](https://shizune.co/investors/profile/gmf-capital)
- Location: Zürich, Switzerland
- Total investments: 3
- Last investment: Feb 2022
- Lead investor: 100%
- Last updated: Sep 2026

Gary Fegel is a seed investor at GMF Capital in Zürich focused on Bitcoin and Security. Gary Fegel - Founder @ GMF Capital

## Contacts

5 contacts available for Gary Fegel: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/gary-fegel?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Bitcoin | 1 | 33% |
| Security | 1 | 33% |
| Biometrics | 1 | 33% |
| Health Care | 1 | 33% |
| Therapeutics | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Funding Round | 1 | 33% |
| Post-IPO Equity | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 67% |
| Israel | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| sMiles | sMiles is a platform for micropayments and micro-incentives in Bitcoin. |  | Seed | Feb 10, 2022 | https://www.smilesbitcoin.com/ |
| InterCure | InterCure is a medical device company that has developed and patented a technology platform for respiratory-based treatment of cardiovascular and pulmonary diseases.The Company has incorporated its "Interactive Respiratory-Pacing" technology platform into several product lines, the first two of which offer a new therapeutic class ofnon-drug treatments for two of the most widespread and costly disease states in the healthcare industry: hypertension and heart failure.InterCure’s first market-ready product, RESPeRATE, is the only FDA-cleared, medical device clinically proven to lower high blood pressure with no side effects.InterCure's heart failure product, InTone™ has successfully completed phase 2a efficacy clinical trials and is expected to be launched when it completes the regulatory approval process.With its outstanding management team, the board of directors and a world-class Scientific Advisory Board, Intercure is poised to become the market leader in patient-focused medical devices that provide non-drug, no-side-effect treatment for some of the world's most prevalent and costly chronic conditions.InterCure was founded in 1994 and is headquartered in Ra'anana, Israel. | $17.5M | Post-IPO Equity | Nov 01, 2018 | http://intercure.com |
| FST Biometrics | FST's unique identification technology offers a seamless access experience. IMID Access software with In Motion Identification technology quickly and accurately identifies users at a distance and in motion. | $15M |  | May 11, 2015 | http://fstbm.com/ |

3 of 3 investments shown.

## Co-investors
- [Goodwater Capital](https://shizune.co/investors/profile/goodwater-capital) — VC Fund, 1 deal together

## About GMF Capital

VC Fund · New York, United States

GMF Capital is a private investment vehicle that engages in private equity and alternative investments across a broad range of asset classes including real estate, healthcare, and structured credit. The management platform's investment approach is driven by its experience and a proprietary network of relationships. It generates outsizerisk-adjusted returns through cash-flowing investments characterized by liquidity and limited exposure to cyclical volatility.GMF Capital began its operations in 2013 and is operating in New York.

1 contacts available at GMF Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Gary Fegel | Founder | https://shizune.co/investors/profile/gary-fegel |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Gary Fegel invest in?

Gary Fegel invests primarily in Bitcoin, Security and Biometrics startups, most often at Seed and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Gary Fegel?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Gary Fegel last invest?

The most recent investment recorded for Gary Fegel closed in Feb 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co